agilon health (NYSE:AGL) Stock Price Down 5.8% – Should You Sell?

Shares of agilon health, inc. (NYSE:AGL) were down 5.8% during trading on Monday . The stock traded as low as $1.85 and last traded at $1.86. Approximately 572,119 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 4,825,294 shares. The stock had previously closed at $1.97.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on AGL shares. Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. TD Cowen dropped their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Macquarie assumed coverage on agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Citigroup dropped their price target on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Finally, Stifel Nicolaus decreased their price objective on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.28.

agilon health Stock Down 6.6 %

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $758.15 million, a P/E ratio of -1.96 and a beta of 0.51. The stock’s fifty day moving average is $2.32 and its two-hundred day moving average is $4.22.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the company posted ($0.06) EPS. As a group, research analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current year.

Insider Buying and Selling at agilon health

In related news, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Diana Mckenzie acquired 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the acquisition, the director now directly owns 51,319 shares in the company, valued at $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 90,000 shares of company stock valued at $198,100 in the last 90 days. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of hedge funds and other institutional investors have recently modified their holdings of AGL. Virtu Financial LLC bought a new stake in agilon health in the 3rd quarter worth approximately $120,000. Geode Capital Management LLC raised its stake in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Barclays PLC lifted its holdings in shares of agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares during the last quarter. XTX Topco Ltd boosted its stake in shares of agilon health by 271.1% in the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after purchasing an additional 87,481 shares in the last quarter. Finally, State Street Corp grew its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.